CDKN2A and neoplasm: In summary, these findings suggest that the upregulation of Cdkn2a in GTML as compared to GMYC might reflect a clinically relevant feature also present and affecting tumor prognosis between MYC-high and MYCN-high human Group 3/4 MBs.